Clinical Trials and Research

The Center for Research on Women’s Health and Reproductive Medicine is currently conducting the following clinical research studies in reproductive medicine:

Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone (Endometrin^®) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)

The purpose of this research study is to learn if a new formulation of subcutaneous injectable progesterone (Progesterone-IBSA) is as effective as a recently FDA approved vaginal preparation (Endometrin®) in helping to maintain pregnancy in an IVF cycle. If you are between the ages of 18 and 42, of healthy weight, in general good health, have had less than 3 prior IVF cycles, and not currently undergoing PGD, then you may be eligible for this study. Progesterone medication and $3500 which could be used to help defray the cost of the IVF cycle will be provided. See details (PDF file). Please contact Tasha Kalista for additional information.

Tasha Kalista
Clinical Research Coordinator
tkalista@stanford.edu
650-725-9977
 

Fragile X Premutations Among Women With Infertility

The purpose of this research study is to see how common the Fragile X (FMR1) premutation is in women with a particular infertility-related ovarian condition called “diminished ovarian reserve”. Genes contain instructions that tell our bodies how to develop and function properly. The blood test used in this study will look for a specific genetic abnormality (called “fragile X or FMR1 premutation”) that may indicate an increased chance for developing premature depletion of eggs, early menopause and, infertility. Stanford University and the University of Virginia are collaborating on this study. Enrolled participants will receive a $50 gift card and free genetic testing. Those participants who wish to learn the results of their genetic testing will also receive genetic counseling free of charge. See details (PDF file). Please contact Angie Morey for additional information.

Angie Morey
Clinical Research Coordinator
morey@stanford.edu
650-498-7625
 

A Study for the Evaluation of Stress Reduction Techniques During In-Vitro Fertilization

The purpose of this research study is to examine the effect of healing touch therapy to reduce stress in women currently undergoing IVF. If you are under the age of 43, undergoing an IVF cycle at the Stanford Fertility and Reproductive Medicine Center, and not currently seeking other energy work (reiki, acupuncture, massage, etc.) then you may be eligible for this study. Women will be randomized to one of three treatment groups: either 3 Healing Touch sessions, or 3 De-sensitization Therapy sessions or no intervention (control group). See details (PDF file). Please contact Allison Carlisle for additional information.

Allison Carlisle
Research Associate
allisnbc@stanford.edu
650-796-8284